{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T13:38:29Z","timestamp":1792330709107,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","pediatric.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pcl.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T03:22:41Z","timestamp":1417144961000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evolution of Modern Treatment of Childhood Acute Leukemia and Cancer"],"prefix":"10.1016","volume":"62","author":[{"given":"Yaddanapudi","family":"Ravindranath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2014.09.005_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0031-3955(16)31309-8","article-title":"Leukemia: current concepts in therapy","volume":"9","author":"Leikin","year":"1962","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.pcl.2014.09.005_bib2","first-page":"1491","article-title":"Long-term survivors in acute leukemia","volume":"25","author":"Burchenal","year":"1965","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2014.09.005_bib3","first-page":"886","article-title":"Acute childhood leukemia: a ten-year study","volume":"100","author":"Zuelzer","year":"1960","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.pcl.2014.09.005_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V24.5.477.477","article-title":"Implications of Long-Term Survival in Acute Stem Cell Leukemia of Childhood Treated with Composite Cyclic Therapy","volume":"24","author":"Zuelzer","year":"1964","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9258(18)57265-3","article-title":"Studies on the inhibitory nature of 4-aminopteroylglutamic acid","volume":"175","author":"Oleson","year":"1948","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pcl.2014.09.005_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2014.09.005_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/(SICI)1096-911X(199910)33:4<409::AID-MPO15>3.0.CO;2-K","article-title":"Forty-five-year follow-up of a childhood leukemia survivor: serendipity or karma?","volume":"33","author":"Ravindranath","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1542\/peds.50.2.246","article-title":"Nine years' experience with \u201ctotal therapy\u201d of childhood acute lymphocytic leukemia","volume":"50","author":"Pinkel","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2014.09.005_bib9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D","article-title":"\u201cTotal therapy\u201d studies of acute lymphocytic leukemia in children. Current results and prospects for cure","volume":"30","author":"Simone","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.pcl.2014.09.005_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V37.3.272.272","article-title":"Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia","volume":"37","author":"Aur","year":"1971","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajh.2830010203","article-title":"IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia","volume":"1","author":"Zeulzer","year":"1976","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pcl.2014.09.005_bib12","first-page":"1441","article-title":"Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate","volume":"36","author":"Wang","year":"1976","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2014.09.005_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1097-0142(197207)30:1<22::AID-CNCR2820300105>3.0.CO;2-B","article-title":"Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer","volume":"30","author":"Djerassi","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.pcl.2014.09.005_bib14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/1097-0142(197306)31:6<1367::AID-CNCR2820310611>3.0.CO;2-6","article-title":"Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy","volume":"31","author":"Jaffe","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.pcl.2014.09.005_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1056\/NEJM198303033080902","article-title":"Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children","volume":"308","author":"Freeman","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2014.09.005_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1985.3.4.485","article-title":"Remission induction of meningeal leukemia with high-dose intravenous methotrexate","volume":"3","author":"Balis","year":"1985","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib17","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1080\/10428190600942769","article-title":"Very high-dose methotrexate (33.6 g\/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute\/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P","volume":"47","author":"Nathan","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pcl.2014.09.005_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.4.3.269","article-title":"Current trends Hematology","volume":"4","author":"Zuelzer","year":"1949","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2014.09.005_bib19","series-title":"Interrelationship of initial WBC, age, and sex in predicting prognosis in childhood Acute Lymphoblastic Leukemia (ALL)","first-page":"214","author":"Coccia","year":"1976"},{"key":"10.1016\/j.pcl.2014.09.005_bib20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1200\/JCO.1991.9.6.1012","article-title":"Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group","volume":"9","author":"Bleyer","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/adc.43.227.107","article-title":"Acute leukaemia 1959\u201364: factors affecting prognosis","volume":"43","author":"Hardisty","year":"1968","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pcl.2014.09.005_bib22","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.182.4119.1355","article-title":"Acute lymphoblastic leukemic cells with T (thymus-derived) lymphocyte markers","volume":"182","author":"Kersey","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.pcl.2014.09.005_bib23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM197504172921604","article-title":"Clinical importance of lymphoblasts with T markers in childhood acute leukemia","volume":"292","author":"Sen","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2014.09.005_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1542\/peds.55.6.889","article-title":"Significance of mediastinal mass in acute lymphoblastic leukemia","volume":"55","author":"Ravindranath","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2014.09.005_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood.V49.3.371.371","article-title":"T\u00a0and B lymphocyte antigen-positive null cell leukemias","volume":"49","author":"Kaplan","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib26","first-page":"193","article-title":"Patterns of gene expression and the cellular origins of human leukaemias","volume":"516","author":"Greaves","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pcl.2014.09.005_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.1981.tb02704.x","article-title":"Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis","volume":"48","author":"Greaves","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pcl.2014.09.005_bib28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood.V61.4.628.628","article-title":"Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts","volume":"61","author":"Greaves","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V55.3.395.395","article-title":"Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia","volume":"55","author":"Sallan","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib30","first-page":"10","article-title":"Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow","volume":"15","author":"Civin","year":"1987","journal-title":"Exp Hematol"},{"key":"10.1016\/j.pcl.2014.09.005_bib31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.2.6151.1529","article-title":"Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis","volume":"2","author":"Secker-Walker","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.pcl.2014.09.005_bib32","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V82.4.1086.1086","article-title":"Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study","volume":"82","author":"Borowitz","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib33","first-page":"431","article-title":"Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia","volume":"3","author":"Ludwig","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.pcl.2014.09.005_bib34","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.1998.16.12.3768","article-title":"Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia","volume":"16","author":"Pui","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2141.1992.tb04560.x","article-title":"Unique genotypic features of infant acute lymphoblastic leukaemia at presentation and at relapse","volume":"80","author":"Biondi","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pcl.2014.09.005_bib36","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.leu.2401886","article-title":"Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a pediatric oncology group study","volume":"14","author":"Harris","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.pcl.2014.09.005_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1651-2227.1981.tb07176.x","article-title":"Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program","volume":"70","author":"Moe","year":"1981","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.pcl.2014.09.005_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00254177","article-title":"Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison","volume":"22","author":"Borsi","year":"1988","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pcl.2014.09.005_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1097-0142(19870701)60:1<5::AID-CNCR2820600103>3.0.CO;2-D","article-title":"A\u00a0comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g\/m2 in children with acute lymphoblastic leukemia","volume":"60","author":"Borsi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.pcl.2014.09.005_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood.V90.2.578","article-title":"Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children","volume":"90","author":"Matherly","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.52.1.155","article-title":"Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity","volume":"52","author":"Galpin","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pcl.2014.09.005_bib42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1097-0142(197609)38:3<1043::AID-CNCR2820380302>3.0.CO;2-U","article-title":"Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): parolonged unmaintained remissions","volume":"38","author":"Djerassi","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.pcl.2014.09.005_bib43","first-page":"703","article-title":"Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection","volume":"61","author":"Bleyer","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.pcl.2014.09.005_bib44","first-page":"1982","article-title":"A\u00a0primate model for study of methotrexate pharmacokinetics in the central nervous system","volume":"37","author":"Poplack","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2014.09.005_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1200\/JCO.1993.11.5.839","article-title":"Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a pediatric oncology group study","volume":"11","author":"Pullen","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib46","first-page":"535","article-title":"L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia","volume":"37","author":"Ortega","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2014.09.005_bib47","first-page":"87","article-title":"Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: a report from the BFM study group","volume":"26","author":"Henze","year":"1981","journal-title":"Haematol Blood Transfus"},{"key":"10.1016\/j.pcl.2014.09.005_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2008-1034450","article-title":"The BFM 76\/79 acute lymphoblastic leukemia therapy study (author's transl)","volume":"193","author":"Henze","year":"1981","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.pcl.2014.09.005_bib49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","article-title":"Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia","volume":"315","author":"Clavell","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2014.09.005_bib50","first-page":"5601","article-title":"Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia","volume":"43","author":"Sallan","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.pcl.2014.09.005_bib51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V85.2.500.500","article-title":"Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia","volume":"85","author":"Matherly","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.005_bib52","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","article-title":"Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society","volume":"4","author":"Patte","year":"1986","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib53","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","article-title":"Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study","volume":"14","author":"Bowman","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.005_bib54","first-page":"1144","article-title":"The use of antagonists of pteroylglutamic acid in controlling Rous chicken sarcoma","volume":"33","author":"Little","year":"1948","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.pcl.2014.09.005_bib55","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","article-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","volume":"314","author":"Link","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2014.09.005_bib56","first-page":"320","volume":"25","author":"Taub","year":"1995","journal-title":"Med Ped Oncol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514001849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514001849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T12:23:55Z","timestamp":1650716635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395514001849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0031395514001849"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2014.09.005","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of Modern Treatment of Childhood Acute Leukemia and Cancer","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2014.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}